Nerve Growth Factor/Tyrosine Kinase A Receptor Pathway Enhances Analgesia in an Experimental Mouse Model of Bone Cancer Pain by Increasing Membrane Levels of Δ-Opioid Receptors.
Bu-Fan Kan,Xing-Yun Liu,Ming-Ming Han,Cheng-Wei Yang,Xia Zhu,Yan Jin,Di Wang,Xiang Huang,Wen-Jie Wu,Tong Fu,Fang Kang,Zhi Zhang,Juan Li
DOI: https://doi.org/10.1097/aln.0000000000004880
IF: 8.986
2024-01-01
Anesthesiology
Abstract:Background:The role of nerve growth factor (NGF)/tyrosine kinase A receptor (TrKA) signaling, which is activated in a variety of pain states, in regulating membrane-associated delta-opioid receptor (mDOR) expression is poorly understood. The hypothesis was that elevated NGF in bone cancer tumors could upregulate mDOR expression in spinal cord neurons and that mDOR agonism might alleviate bone cancer pain. Methods:Bone cancer pain (BCP) was induced by inoculating Lewis lung carcinoma cells into the femoral marrow cavity of adult C57BL/6J mice of both sexes. Nociceptive behaviors were evaluated by the von Frey and Hargreaves tests. Protein expression in the spinal dorsal horn of animals was measured by biochemical analyses, and excitatory synaptic transmission was recorded in miniature excitatory synaptic currents. Results:The authors found that mDOR expression was increased in BCP mice (BCP vs. sham, mean +/- SD: 0.18 +/- 0.01 g vs. mean +/- SD: 0.13 +/- 0.01 g, n = 4, P < 0.001) and that administration of the DOR agonist deltorphin 2 (Del2) increased nociceptive thresholds (Del2 vs. vehicle, median [25th, 75th percentiles]: 1.00 [0.60, 1.40] g vs. median [25th, 75th percentiles]: 0.40 [0.16, 0.45] g, n = 10, P = 0.001) and reduced miniature excitatory synaptic current frequency in lamina II outer neurons (Del2 vs. baseline, mean +/- SD: 2.21 +/- 0.81 Hz vs. mean +/- SD: 2.43 +/- 0.90 Hz, n = 12, P < 0.001). Additionally, NGF expression was increased in BCP mice (BCP vs. sham, mean +/- SD: 0.36 +/- 0.03 vs. mean +/- SD: 0.16 +/- 0.02, n = 4, P < 0.001), and elevated NGF was associated with enhanced mDOR expression via TrKA signaling. Conclusions:Activation of mDOR produces analgesia that is dependent on the upregulation of the NGF/TrKA pathway by increasing mDOR levels under conditions of BCP in mice.